Fosun Pharma (02196.HK) completes the issuance of the second phase of Science and Technology Innovation Bonds for 2025.

The Zhtng financial news app reported that Fosun Pharma (02196.HK) has announced that the company recently completed the issuance of the second phase of technology innovation bonds for the year 2025 within the registered quota under the prospectus. The bond is named "25 Fosun Pharma MTN002" (technology innovation bond), with a total issuance amount of 1 billion yuan, a term of 2 years, an issuance price of 100 yuan per hundred yuan, and an issuance interest rate of 2.70%.